Miyabi Yamakita
Stock Analyst at Jefferies
(1.45)
# 3,416
Out of 4,421 analysts
84
Total ratings
50%
Success rate
-0.5%
Average return
Main Sectors:
Stocks Rated by Miyabi Yamakita
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4592 SanBio Company Limited | Upgraded: Hold | ¥1,500 → ¥1,200 | $1,020.00 | +17.65% | 5 | Jun 15, 2026 | |
| TYO: 2413 M3, Inc. | Maintained: Hold | ¥1,800 → ¥1,600 | $1,628.50 | -1.75% | 9 | May 28, 2026 | |
| TYO: 4547 Kissei Pharmaceutical Co., Ltd. | Maintained: Buy | ¥5,400 → ¥4,800 | $3,985.00 | +20.45% | 7 | May 25, 2026 | |
| TYO: 4516 Nippon Shinyaku Co., Ltd. | Maintained: Hold | ¥3,800 → ¥5,200 | $3,960.00 | +31.31% | 3 | Apr 28, 2026 | |
| TYO: 4552 JCR Pharmaceuticals Co., Ltd. | Upgraded: Buy | ¥750 → ¥900 | $455.00 | +97.80% | 4 | Apr 16, 2026 | |
| TYO: 2784 Alfresa Holdings Corporation | Maintained: Hold | ¥2,300 → ¥2,400 | $2,181.00 | +10.04% | 4 | Apr 14, 2026 | |
| TYO: 7459 MediPal Holdings Corporation | Maintained: Hold | ¥2,500 → ¥2,700 | $2,578.00 | +4.73% | 9 | Apr 14, 2026 | |
| TYO: 9987 Suzuken Co., Ltd. | Maintained: Buy | ¥6,800 → ¥7,100 | $4,903.00 | +44.81% | 7 | Apr 14, 2026 | |
| TYO: 8129 Toho Holdings Co., Ltd. | Maintained: Hold | ¥5,800 → ¥5,000 | $3,757.00 | +33.08% | 10 | Apr 14, 2026 | |
| TYO: 4483 JMDC Inc. | Reiterated: Buy | ¥5,600 → ¥6,400 | $2,694.00 | +137.56% | 6 | Nov 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥620 | $105.00 | +490.48% | 1 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥620 → ¥710 | $258.00 | +175.19% | 3 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥2,100 | $1,623.50 | n/a | 13 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥2,000 | $961.00 | n/a | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ¥1,900 → ¥2,800 | $946.90 | n/a | 2 | Feb 27, 2025 |
SanBio Company Limited
Jun 15, 2026
Upgraded: Hold
Price Target: ¥1,500 → ¥1,200
Current: $1,020.00
Upside: +17.65%
M3, Inc.
May 28, 2026
Maintained: Hold
Price Target: ¥1,800 → ¥1,600
Current: $1,628.50
Upside: -1.75%
Kissei Pharmaceutical Co., Ltd.
May 25, 2026
Maintained: Buy
Price Target: ¥5,400 → ¥4,800
Current: $3,985.00
Upside: +20.45%
Nippon Shinyaku Co., Ltd.
Apr 28, 2026
Maintained: Hold
Price Target: ¥3,800 → ¥5,200
Current: $3,960.00
Upside: +31.31%
JCR Pharmaceuticals Co., Ltd.
Apr 16, 2026
Upgraded: Buy
Price Target: ¥750 → ¥900
Current: $455.00
Upside: +97.80%
Alfresa Holdings Corporation
Apr 14, 2026
Maintained: Hold
Price Target: ¥2,300 → ¥2,400
Current: $2,181.00
Upside: +10.04%
MediPal Holdings Corporation
Apr 14, 2026
Maintained: Hold
Price Target: ¥2,500 → ¥2,700
Current: $2,578.00
Upside: +4.73%
Suzuken Co., Ltd.
Apr 14, 2026
Maintained: Buy
Price Target: ¥6,800 → ¥7,100
Current: $4,903.00
Upside: +44.81%
Toho Holdings Co., Ltd.
Apr 14, 2026
Maintained: Hold
Price Target: ¥5,800 → ¥5,000
Current: $3,757.00
Upside: +33.08%
JMDC Inc.
Nov 2, 2025
Reiterated: Buy
Price Target: ¥5,600 → ¥6,400
Current: $2,694.00
Upside: +137.56%
Oct 16, 2025
Maintained: Buy
Price Target: ¥620
Current: $105.00
Upside: +490.48%
Aug 15, 2025
Maintained: Buy
Price Target: ¥620 → ¥710
Current: $258.00
Upside: +175.19%
Apr 21, 2025
Maintained: Hold
Price Target: ¥2,100
Current: $1,623.50
Upside: n/a
Mar 13, 2025
Maintained: Buy
Price Target: ¥2,000
Current: $961.00
Upside: n/a
Feb 27, 2025
Upgraded: Buy
Price Target: ¥1,900 → ¥2,800
Current: $946.90
Upside: n/a